Insider Stock Trading History of Stebbins Lucinda H


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Stebbins Lucinda H since year 2005. The trader's CIK number is 1236462. At the time of this reporting, Stebbins Lucinda H is the Director of H&q Life Sciences Investors . (stock ticker symbol HQL). See this page for all insider trading activities at H&q Life Sciences Investors .

Note that in the past STEBBINS LUCINDA H also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Stebbins Lucinda H since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2015-06-29 HQL H&q Life Sciences Investors Buy 1,000 28.17 28,170
2015-06-29 HQH H&q Healthcare Investors Buy 2,000 35.74 71,480
2014-12-03 THQ Tekla Healthcare Opportunities Fund Buy 1,000 20.07 20,066
2009-09-03 HQH H&q Healthcare Investors Buy 1,000 10.51 10,510
2009-05-18 HQL H&q Life Sciences Investors Buy 1,500 8.14 12,210
2008-02-25 HQL H&q Life Sciences Investors Buy 1,800 12.65 22,770
2007-12-31 HQL H&q Life Sciences Investors Sale 2,000 13.12 26,240
2007-08-21 HQH H&q Healthcare Investors Buy 1,000 16.63 16,630
2007-02-09 HQL H&q Life Sciences Investors Buy 3,000 14.98 44,928
2006-12-27 HQH H&q Healthcare Investors Buy 3,000 16.41 49,227

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Stebbins Lucinda H (Director of H&q Life Sciences Investors at the time of this reporting) see the Securities and Exchange Commission (SEC) website.